1. Home
  2. BGT vs CGEN Comparison

BGT vs CGEN Comparison

Compare BGT & CGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BlackRock Floating Rate Income Trust

BGT

BlackRock Floating Rate Income Trust

HOLD

Current Price

$10.97

Market Cap

317.3M

Sector

Finance

ML Signal

HOLD

Logo Compugen Ltd.

CGEN

Compugen Ltd.

HOLD

Current Price

$2.81

Market Cap

270.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BGT
CGEN
Founded
N/A
1993
Country
United States
Israel
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
317.3M
270.4M
IPO Year
2004
2001

Fundamental Metrics

Financial Performance
Metric
BGT
CGEN
Price
$10.97
$2.81
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$5.00
AVG Volume (30 Days)
101.7K
534.9K
Earning Date
01-01-0001
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$75.09
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.22
$1.29
52 Week High
$12.76
$3.24

Technical Indicators

Market Signals
Indicator
BGT
CGEN
Relative Strength Index (RSI) 50.00 55.79
Support Level $10.83 $1.46
Resistance Level $11.14 $3.24
Average True Range (ATR) 0.08 0.17
MACD -0.00 -0.02
Stochastic Oscillator 40.32 38.13

Price Performance

Historical Comparison
BGT
CGEN

About BGT BlackRock Floating Rate Income Trust

Blackrock Floating Rate Income Trust is a diversified closed-end management investment company. Its investment objective is to provide a high level of current income. The company, as a secondary objective, also focuses on preservation of capital to the extent consistent with its primary objective of high current income. The Trust seeks to achieve its investment objectives by investing in worl-wide portfolio of floating rate securities, including investing a substantial amount in U.S. and non-U.S. senior secured floating rate loans (Senior Loans), made to corporate and other business entities.

About CGEN Compugen Ltd.

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing Unigen, its AI/ML-powered computational discovery capabilities, to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs: COM701, COM902, rilvegostomig, and GS-0321 (previously COM503), targeting immune checkpoints the company discovered computationally. The company's revenues are generated mainly from collaborative and license agreements. Geographically, it generates maximum revenue from the United Kingdom, and the rest from the United States.

Share on Social Networks: